shieldtherapeutics.com Report : Visit Site

Technical data of the shieldtherapeutics.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host shieldtherapeutics.com. Currently, hosted in United Kingdom and its service provider is UKfastnet Ltd .

the related websites

medicines.org.uk lindsays.co.uk bronzeshield.com telegraph.co.uk magiglideuk.co.uk paintshield.co.uk services.runescape.com dailymail.co.uk link.springer.com beaconmedaes.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

about explore section our strategy & values people lead products explore section feraccru ® pipeline product candidates investors explore section share price summary rns news corporate governance corporate documents presentations advisor contacts aim rule 26 financial calendar news events careers explore section all jobs contact us contact us about about shield therapeutics is a high potential, commercial stage specialty-pharma company. we pride ourselves on providing solutions to unmet medical needs and delivering value to our shareholders. explore section our strategy & values people lead products lead products shield has a rare opportunity to build an integrated, highly profitable specialty pharma business. in this section you can learn more about our lead product, and about our second asset. explore section feraccru ® pipeline product candidates investors investors shield is well positioned to become a fast growing, independent, international specialty pharmaceutical company due to the strength of its products and team, and with great thanks to all of our supportive shareholders. explore section share price summary rns news corporate governance aim rule 26 corporate documents presentations advisor contacts financial calendar news events careers careers as a unified team we are constantly driven by and committed to our goals, seeking to deliver them with transparency and respect. being consistent to this vision, while enjoying the journey, has brought us to where we are today. explore section all jobs welcome to shield therapeutics find out about us our people driven by and committed to our goals our investors delivering more value to our shareholders careers offering opportunity, ambition and development specialty pharmaceutical company providing solutions to unmet medical needs. shield therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of unmet medical need. find out more our products a treatment for iron deficiency anaemia our lead product, feraccru®, is a novel oral treatment for iron deficiency anaemia (ida) which, following receipt of marketing authorisation in early 2016, is now commercially available for use initially in patients with inflammatory bowel disease associated ida. find out more shares stx june 14 2018 at 2:07 am 40.00 1.00 | 2.560% news preliminary results for the year ended 31 december 2017 read more > view full share summary pm society awards gold winner for events & exhibitions awarded company of the year at the 2016 bionow awards 5 jun 2018 shield therapeutics plc announces directorate change for further details please see the press release below: stx_rns board change 5 jun 2018 shield therapeutics plc notice of annual general meeting… stx_rns agm notice 11 apr 2018 preliminary results for the year ended 31 december… shield therapeutics plc (lse:stx) today announces its preliminary group results for the year ended 31 december 2017. for full details… view more news articles sign up for news email address * gdpr please tick this box if you'd like to receive information and updates from us about our products. you can unsubscribe at any time. sign up london, uk 120 new cavendish street london w1w 6xx t +44 (0) 207 186 8500 e [email protected] newcastle, uk northern design centre baltic business quarter gateshead quays, ne8 3df t +44 (0) 191 511 8500 e [email protected] wollerau, switzerland sihleggstrasse 23, 8832 wollerau switzerland t +41 (0) 435 080 781 e [email protected] munich, germany münchen 5 höfe theatinerstrasse 11 de- 80333 münchen t +49 (0) 89 710 42 2246 e [email protected] © 2018 shield therapeutics. privacy policy . terms of use . cookie policy

URL analysis for shieldtherapeutics.com

https://www.shieldtherapeutics.com///about/our-strategy-values/
https://www.shieldtherapeutics.com/shield-therapeutics-plc-announces-directorate-change/
https://www.shieldtherapeutics.com///investors/advisor-contacts/
https://www.shieldtherapeutics.com///about/
https://www.shieldtherapeutics.com///investors/presentations/
https://www.shieldtherapeutics.com/product/feraccru/
https://www.shieldtherapeutics.com//mailto:[email protected]
https://www.shieldtherapeutics.com///careers/jobs
https://www.shieldtherapeutics.com///careers/
https://www.shieldtherapeutics.com///investors/share-price-summary
https://www.shieldtherapeutics.com///news/
https://www.shieldtherapeutics.com///about#meet-the-team
https://www.shieldtherapeutics.com///investors/corporate-governance/
https://www.shieldtherapeutics.com///lead-products/
https://www.shieldtherapeutics.com//mailto:[email protected]

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: SHIELDTHERAPEUTICS.COM
Registry Domain ID: 1519823769_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.meshdigital.com
Registrar URL: http://www.meshdigital.com
Updated Date: 2017-09-12T04:57:53Z
Creation Date: 2008-09-17T08:33:23Z
Registry Expiry Date: 2018-09-17T08:33:23Z
Registrar: Mesh Digital Limited
Registrar IANA ID: 1390
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.Z1HOST.NET
Name Server: NS2.Z1HOST.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-11T06:47:41Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Mesh Digital Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =shieldtherapeutics.com

  PORT 43

  TYPE domain

DOMAIN

  NAME shieldtherapeutics.com

  CHANGED 2017-09-12

  CREATED 2008-09-17

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS1.Z1HOST.NET 79.170.40.2

  NS2.Z1HOST.NET 79.170.43.3

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .